{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:59:06Z","timestamp":1773655146969,"version":"3.50.1"},"reference-count":0,"publisher":"Australian Centre for Disease Control","license":[{"start":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T00:00:00Z","timestamp":1072828800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Commun Dis Intell (2018)"],"abstract":"<jats:p>The World Health Organization's Western Pacific Region (WHO WPR) long standing programme for surveillance of antimicrobial resistance in\u00a0Neisseria gonorrhoeae,\u00a0GASP, continued in 2002. Seventeen countries contributed data on about 11,500 gonococci by determining susceptibility patterns using standardised methodologies. Resistance to quinolone and penicillin antibiotics remained widely dispersed and at historically high levels. Gonococci with decreased susceptibility to third generation cephalosporins were again observed in several centres. Spectinomycin resistance was infrequently encountered. Control of gonorrhoea in the WHO WPR is compromised by the further reduction in options for cheap and effective treatment of gonorrhoea.\u00a0Commun Dis Intell\u00a02003;27:488-491.<\/jats:p>","DOI":"10.33321\/cdi.2003.27.77","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:43:36Z","timestamp":1749602616000},"page":"488-491","source":"Crossref","is-referenced-by-count":3,"title":["Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002"],"prefix":"10.33321","volume":"27","author":[{"given":"John","family":"Tapsall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WHO Western Pacific Gonococcal AMR Surveillance Programme","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18788","published-online":{"date-parts":[[2003,12,31]]},"container-title":["Communicable Diseases Intelligence"],"original-title":[],"link":[{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/download\/2457\/3337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/download\/2457\/3337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:43:40Z","timestamp":1749602620000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojs.cdi.cdc.gov.au\/index.php\/cdi\/article\/view\/2457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,31]]},"references-count":0,"URL":"https:\/\/doi.org\/10.33321\/cdi.2003.27.77","relation":{},"ISSN":["2209-6051"],"issn-type":[{"value":"2209-6051","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,31]]}}}